Business Wire

The Kavli Foundation Launches Two Kavli Centers for Ethics, Science, and the Public to Engage the Public in Exploring Ethical Implications Born from Scientific Discovery

Share

Scientific discoveries deepen our understanding of nature and ourselves, with the potential to transform our everyday lives, yet can raise ethical concerns or risks for society.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20211209005349/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

Brooke Smith, Director of Public Engagement, The Kavli Foundation (Photo: Business Wire)

Cutting-edge neuroscience, genetics, and artificial intelligence are a few examples that are driving the need to discuss: Who bears responsibility for broad ethical considerations of scientific discoveries? When is it optimal to consider implications and risks? How can the public be empowered to participate in these discussions?

Two Kavli Centers for Ethics, Science, and the Public – at the University of California, Berkeley, and the University of Cambridge – are launching to engage the public in identifying and exploring ethical considerations and impacts born from scientific discovery.

The Kavli Foundation’s vision for the centers is a paradigm shift to meet an as-yet unmet need within science: a proactive and sustained effort that is intentional in connecting the public, scientists, ethicists, social scientists, and science communicators early in the process of scientific discoveries to identify and discuss potential impacts on society.

“We’re embarking on a democratization of the way we think, collaborate, and communicate about scientific discoveries and their ethical aspects – and ensuring the public is included,” said The Kavli Foundation President Cynthia Friend. “It’s long past due for this to happen.”

Until now, there hasn’t been a sustained and proactive venture to address ethical implications born from scientific discovery that involves the public early and intentionally in the scientific process. And while there is increasing recognition within the scientific community that the public should be involved, mechanisms and infrastructure to do this are lacking. The public is too often left out of these important discussions, or they are brought in too late.

“With the Kavli Centers for Ethics, Science, and the Public, we are taking necessary action to create the infrastructure that enables early and intentional public engagement in the ethical considerations born from scientific discoveries,” remarked The Kavli Foundation Director of Public Engagement Brooke Smith.

Two centers were selected for this new venture based on their vision, approach, and experience. While both are multi-faceted and complementary in their approaches working across disciplines in the sciences and humanities, each will have an initial focus that is unique.

The Kavli Center for Ethics, Science, and the Public at UC Berkeley will reimagine how scientists are trained, beginning in the fields of neuroscience, genetics, and artificial intelligence. Leading the center is AI expert Stuart Russell, along with Nobel-Prize Laureate Saul Perlmutter, who provided some of the first evidence that the expansion of the universe is accelerating; Nobel and Kavli Prize Laureate Jennifer Doudna, known for her discovery of the gene-editing tool CRISPR; theoretical and moral philosopher Jay Wallace; bioethicist Jodi Halpern; neuroscientist Jack Gallant; and historian and writer Elena Conis.

“The impetus from The Kavli Foundation has helped to mobilize Berkeley’s unparalleled resources in the humanities, social sciences, natural sciences, and engineering to collaborate on addressing one of humanity's most pressing problems: how to ensure that our rapidly advancing scientific and technological capabilities are directed towards the interests of humanity,” said Stuart Russell, who serves as the inaugural Director of the Kavli Center for Ethics, Science, and the Public at UC Berkeley.

In a unique collaboration with Wellcome Connecting Science, the Kavli Center for Ethics, Science, and the Public at the University of Cambridge will be led by internationally recognized social scientist and genetic counsellor Anna Middleton; supported by sociologist and bioethicist Richard Milne; and journalist and broadcaster Catherine Galloway; with creative industry expertise from broadcaster Vivienne Parry, OBE; sociology of education expertise from Susan Robertson; and genomics and public engagement expertise from Julian Rayner. Drawing on a network of experts in ethics and public engagement from the UK, China, Russia, India, and Japan, the new center will explore how ethical implications raised by science are tackled in different cultural contexts within the domains of genomics, big data, health research, and emerging technologies.

“From the discovery of DNA’s structure to sequencing 20% of the world’s COVID virus and the development of the first artificial intelligence, Cambridge has been at the cutting edge of science for centuries,” remarked Anna Middleton, director for the Kavli Center for Ethics, Science, and the Public at the University of Cambridge. “Through collaboration with experts in popular culture we will find the evidence base to communicate complex ideas around the ethical issues raised by science so that all of us can share in decision making around the implications of science for society.”

The idea for the Centers was sparked by The Kavli Foundation’s work and observations in science and society, including research at the 20 Kavli Institutes globally, where inspiring and transformative science is being done—ranging from decoding brain activity to fabricating artificial cells.

“This is a long-overdue beginning of an important journey for the scientific community, and we look forward to the impact the Kavli Centers for Ethics, Science, and the Public will have on the future role of science within society,” said Friend.

The Kavli Foundation is dedicated to advancing science for the benefit of humanity. The foundation’s mission is implemented through Kavli research institutes globally and programs that support basic science in the fields of astrophysics, nanoscience, neuroscience, and theoretical physics; initiatives that strengthen the relationship between science and society; and prizes and awards including the international Kavli Prizes and the AAAS Kavli Science Journalism Awards. Learn more at kavlifoundation.org and follow @kavlifoundation.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Stacey Bailey
sbailey@kavlifoundation.org

About Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

(c) 2018 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Altasciences Chosen by Virpax Pharmaceuticals, Inc. to Conduct First-in-Human Study of Epoladerm™ for Chronic Pain Associated with Osteoarthritis of the Knee21.1.2022 17:00:00 CET | Press release

Altasciences is pleased to have been chosen by Virpax® Pharmaceuticals, Inc. (“Virpax”) (NASDAQ:VRPX) to conduct a first-in-human study of Epoladerm™ (diclofenac epolamine) for chronic pain associated with osteoarthritis of the knee. This treatment is supplied in a pre-filled device for administration as a topical spray film. The study will be conducted in Q2 2022 at Altasciences’ clinical pharmacology unit in Montreal, Canada. “We look forward to working with Altasciences to accelerate the development of this analgesic treatment and provide robust data in support of the 505(b)(2) FDA approval pathway,” stated Virpax’s Chairman & CEO, Anthony P. Mack. Virpax’s proprietary technology provides a pre-filled canister for the therapeutic application of a clear, fast-drying spray film that is thinner than a standard liquid bandage. This technology offers convenience and eliminates the need for messy creams or gels. Altasciences leverages decades of experience conducting first-in-human clinic

OMRON Healthcare Remote Patient Monitoring Services Win “Best of” Honors at CES 202221.1.2022 16:21:00 CET | Press release

OMRON Healthcare, Inc., the global leader in remote blood pressure monitoring and personal health technology, spotlighted its new remote patient monitoring services at the 2022 Consumer Electronics Show (CES) and won “Best of” honors for its offerings in the U.K. and U.S: Hypertension Plus by OMRON in the U.K. was selected as a TWICE Picks Awards winner for the 2022 TWICE, Residential Systems and TechRadar Pro Picks Awards VitalSight™ by OMRON in the U.S. was recognised as an INSIDER “Best of” CES selection These remote patient monitoring services gained recognition at the world’s largest innovation show as breakthrough health technology designed to foster greater active health condition management, strengthen the patient-physician connection, and guide behavior change to reduce health risks, while advancing the company’s mission of Going for Zero heart attacks and strokes. “OMRON developed Hypertension Plus as the first step toward transforming chronic care in the U.K., while VitalSig

Schlumberger Announces Fourth-Quarter and Full-Year 2021 Results21.1.2022 12:50:00 CET | Press release

Schlumberger Limited (NYSE: SLB) today reported results for the fourth-quarter and full-year 2021. Fourth-Quarter Results (Stated in millions, except per share amounts)Three Months EndedChangeDec. 31, 2021Sept. 30, 2021Dec. 31, 2020SequentialYear-on-yearRevenue* $6,225 $5,847 $5,532 6% 13% Income before taxes - GAAP basis $755 $691 $471 9% 60% Net income - GAAP basis $601 $550 $374 9% 61% Diluted EPS - GAAP basis $0.42 $0.39 $0.27 8% 56% Adjusted EBITDA** $1,381 $1,296 $1,112 7% 24% Adjusted EBITDA margin** 22.2% 22.2% 20.1% 2 bps 208 bps Pretax segment operating income** $986 $908 $654 9% 51% Pretax segment operating margin** 15.8% 15.5% 11.8% 31 bps 401 bps Net income, excluding charges & credits** $587 $514 $309 14% 90% Diluted EPS, excluding charges & credits** $0.41 $0.36 $0.22 14% 86% Revenue by Geography International $4,898 $4,675 $4,343 5% 13% North America* 1,281 1,129 1,167 13% 10% Other 46 43 22 n/m n/m $6,225 $5,847 $5,532 6% 13% *Schlumberger divested certain businesses i

ZuluTrade - World’s Largest Social Trading Platform Joins the Finvasia Group21.1.2022 12:08:00 CET | Press release

ZuluTrade is strongly positioned to become the biggest and the largest broker neutral social trading platform with acquisition by Finvasia Group. 2022 will see ZuluTrade strengthening its current capabilities and widen its product line by venturing into different markets and financial instruments. The expansion will include contemporary asset classes like cryptocurrencies and traditional asset classes like stocks and bonds. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220120005780/en/ ZuluTrade - World’s Largest Social Trading Platform Joins the Finvasia Group (Graphic: Business Wire) ZuluTrade has been at the forefront of copy trading for more than a decade and has helped over a million investors across more than 100 countries trade a volume of over USD 2 trillion. ZuluTrade 2.0 Future plans include launching a more engaging social investing platform with enhanced social and technology features, built on ZuluTrade’s curre

Ipsen Nominates Karen Witts as New Independent Board Member21.1.2022 07:00:00 CET | Press release

Regulatory News: This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220120006035/en/ Karen Witts (Photo: Business Wire) Ipsen (Euronext: IPN; ADR: IPSEY) announced today the nomination of Karen Witts to its Board of Directors as independent member. Karen Witts was Group CFO at Compass Group Plc until October 2021. Compass is the world’s leading food service company, operating in 43 countries and employing more than 500k people. She was responsible for corporate strategy and planning, business performance management and reporting, financial reporting and control, tax and treasury activities, M&A, internal audit and enterprise risk management, investor relations, and led the digital and technology function. Prior to this, Karen was Group CFO at Kingfisher Plc, the international home improvement company. She has also held various senior strategic finance positions at companies including Vodafone Group Services Ltd, and BT Plc. She

Peru Is Presenting Itself at FITUR 2022 as a Bio-safe Destination, Committed to Outdoor Experiences21.1.2022 02:48:00 CET | Press release

Peru is in attendance at the 42nd edition of FITUR 2022 to position itself as a safe and ready destination for international travellers, motivating them to rediscover the South American country, reported the Comisión de Promoción del Perú para la Exportación y el Turismo [Peruvian Export and Tourism Promotion Commission] (PROMPERÚ). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220119005812/en/ Inauguration of the Peru stand at FITUR 2022 by the executive president of PROMPERÚ, Amora Carbajal. ©PROMPERÚ In line with its promotion and recovery strategy, Peru is presenting a delegation made up of 19 co-exhibitors in order to show off the best of its tourist offering in the nature, adventure and culture segments. Likewise, it announced its collaboration with the Asociación Española de Agencias de Incentivos – IdeMICE, in order to enhance the attributes of the destination in this segment. In addition, the executive president of

McAfee Continues to Provide Leading Online Protection to Consumers21.1.2022 02:40:00 CET | Press release

Today, McAfee Corp. (NASDAQ: MCFE, “McAfee”), a global leader in online protection, provided an update regarding its pure-play consumer offering and the previously announced divestiture of its enterprise business. In July 2021, McAfee completed the sale of its enterprise business. This transaction allowed McAfee to singularly focus on its consumer business and accelerate its strategy to be the leader in online protection for consumers. “McAfee continues to safeguard the privacy, security and identity of our consumers as the digital world evolves rapidly,” said Gagan Singh, Executive Vice President & Chief Revenue and Product Officer, McAfee. “We continue to stand firm that meaningful protection is a personal right for consumers and have recently rolled out major updates and industry firsts, including McAfee Total Protection and Protection Score, that look out for consumers online, including their privacy and identity.” The McAfee Enterprise business was purchased by Symphony Technology